A powerful new diagnostic technology combining digital PCR with melting curve analysis is poised to transform early detection for one of oncology's most challenging diseases.
Explore how liquid biopsy technology is revolutionizing pancreatic cancer detection by tracking mutant KRAS DNA in blood samples.
Discover how pancreatic cancer's secretome, particularly gelsolin, could revolutionize early detection and treatment of this deadly disease.